The policy also includes expectations that researchers seek the most liberal data-sharing permissions from study participants to aid future research.
“Everyone is eager to see the incredible deluge of molecular discoveries about disease translated into prevention, diagnostics and therapeutics for patients,” said Kathy Hudson, PhD, NIH deputy director for science, outreach and policy. “The collective knowledge achieved through data sharing benefits researchers and patients alike, but it must be done carefully. The GDS policy outlines the responsibilities of investigators and institutions that are using the data and also encourages researchers to get consent from participants for future unspecified use of their genomic data.”
More articles on genomic data:
Health IT Startup to Watch: Syapse
MD Anderson Cancer Center to Invest up to $3B in New Cancer Program
Healthcare Organizations Use Data Creatively for Better Health Outcomes
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
